Bharat Biotech Gets Rights To Make 100 Crores Doses Of Nasal Adenovirus Vaccine
Fact Check: First Dose Of COVAXIN Administered On Bharat Biotech Vice President VK Srinivas?
COVAXIN: Indias First COVID-19 Vaccine Candidate Set For Phase I, II Human Trials
Oxford University Starts COVID-19 Vaccine Trials, First Volunteer Injected